A venture capital firm headquartered in Western Europe focuses on deeptech, specifically covering their thesis of transformative and frontier technology – technical solutions that can vastly change and command a huge market. The firm invests in Pre-Seed and Seed stage companies. Typical check size is a fixed amount of $500k USD, and the firm can act both as a lead or co-investor. The firm is geographically agnostic, but has made most of its investments in Europe and the USA.
In terms of life science, the firm considers digital health and sometimes device or diagnostic companies that have an AI component or some sort of consumer facing platform. The firm can go as early as the pre-revenue concept stage, right through to those with a sustained record of aggressive growth.
The firm does not have management team requirements.
If you are interested in more information about this investor and other investors tracked by LSN, please email salescore@lifesciencenation.com.
Next Phase Newsletter 
Leave a comment